These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 8450157)

  • 41. Distortion of intracardiac electrograms following defibrillator shocks for atrial tachyarrhythmias.
    Khalighi K; Florin TJ; Peters RW; Shorofsky SR; Gold MR
    Pacing Clin Electrophysiol; 1997 Jun; 20(6):1682-5. PubMed ID: 9227767
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Appropriate sensing of ventricular fibrillation after failed shocks in a transvenous cardioverter-defibrillator system.
    Ellis JR; Martin DT; Venditti FJ
    Circulation; 1994 Oct; 90(4):1820-5. PubMed ID: 7923667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator.
    Swerdlow CD; Chen PS; Kass RM; Allard JR; Peter CT
    J Am Coll Cardiol; 1994 May; 23(6):1342-55. PubMed ID: 8176092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implantable Cardioverter Defibrillator Programming Characteristics, Shocked Rhythms, and Survival Among Patients Under Thirty Years of Age.
    Chang PM; Powell BD; Jones PW; Carter N; Hayes DL; Saxon LA
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1183-1190. PubMed ID: 27334356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ventricular pacing induced ventricular tachycardia in patients with implantable cardioverter defibrillators.
    Roelke M; O'Nunain S; Osswald S; Trouton TG; Harthorne JW; Garan H; Ruskin JN
    Pacing Clin Electrophysiol; 1995 Mar; 18(3 Pt 1):486-91. PubMed ID: 7770372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Shock Reduction With Antitachycardia Pacing Before and During Charging for Fast Ventricular Tachycardias in Patients With Implantable Defibrillators.
    Dallaglio PD; Anguera I; Martínez Ferrer JB; Pérez L; Viñolas X; Porres JM; Fontenla A; Alzueta J; Martínez JG; Rodríguez A; Basterra N; Sabaté X
    Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):709-717. PubMed ID: 29242102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differentiation of ventricular and supraventricular tachycardias based on the analysis of the first postpacing interval after sequential anti-tachycardia pacing in implantable cardioverter-defibrillator patients.
    Arenal A; Ortiz M; Peinado R; Merino JL; Quesada A; Atienza F; Alberola AG; Ormaetxe J; Castellanos E; Rodriguez JC; Pérez N; García J; Boluda L; del Prado M; Artés A
    Heart Rhythm; 2007 Mar; 4(3):316-22. PubMed ID: 17341396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intracardiac J-point elevation before the onset of polymorphic ventricular tachycardia and ventricular fibrillation in patients with an implantable cardioverter-defibrillator.
    Tereshchenko LG; McCabe A; Han L; Sur S; Huang T; Marine JE; Cheng A; Spragg DD; Sinha S; Calkins H; Stein K; Tomaselli GF; Berger RD
    Heart Rhythm; 2012 Oct; 9(10):1594-602. PubMed ID: 22750217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure.
    Gunderson BD; Gillberg JM; Wood MA; Vijayaraman P; Shepard RK; Ellenbogen KA
    Heart Rhythm; 2006 Feb; 3(2):155-62. PubMed ID: 16443529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of device activation for ventricular arrhythmias and survival in patients with implantable pacemakers/defibrillators. CADENCE Investigators.
    Reiter MJ; Fain ES; Senelly KM; Robertson AD
    Pacing Clin Electrophysiol; 1994 Sep; 17(9):1487-98. PubMed ID: 7991419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discrimination of ventricular tachycardia from supraventricular tachycardia by a downloaded wavelet-transform morphology algorithm: a paradigm for development of implantable cardioverter defibrillator detection algorithms.
    Swerdlow CD; Brown ML; Lurie K; Zhang J; Wood NM; Olson WH; Gillberg JM
    J Cardiovasc Electrophysiol; 2002 May; 13(5):432-41. PubMed ID: 12030523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inadequacy of qualitative implantable cardioverter defibrillator electrogram analysis to distinguish supraventricular from ventricular tachycardia due to electrogram changes during normally conducted complexes.
    Hallett N; Monahan K; Casavant D; Epstein L; Josephson M
    Pacing Clin Electrophysiol; 1997 Jun; 20(6):1723-6. PubMed ID: 9227776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of failed defibrillation shocks on electrogram amplitude in a nonintegrated transvenous defibrillation lead system.
    Brady PA; Friedman PA; Stanton MS
    Am J Cardiol; 1995 Sep; 76(8):580-4. PubMed ID: 7677081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses.
    Pires LA; Lehmann MH; Steinman RT; Baga JJ; Schuger CD
    J Am Coll Cardiol; 1999 Jan; 33(1):24-32. PubMed ID: 9935004
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Feedback to providers improves evidence-based implantable cardioverter-defibrillator programming and reduces shocks.
    Silver MT; Sterns LD; Piccini JP; Joung B; Ching CK; Pickett RA; Rabinovich R; Liu S; Peterson BJ; Lexcen DR;
    Heart Rhythm; 2015 Mar; 12(3):545-553. PubMed ID: 25460168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circadian variation of ventricular arrhythmia recurrences after cardioverter-defibrillator implantation in patients with healed myocardial infarcts.
    Mallavarapu C; Pancholy S; Schwartzman D; Callans DJ; Heo J; Gottlieb CD; Marchlinski FE
    Am J Cardiol; 1995 Jun; 75(16):1140-4. PubMed ID: 7762501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical experience with a new detection algorithm for differentiation of supraventricular from ventricular tachycardia in a dual-chamber defibrillator.
    Sinha AM; Stellbrink C; Schuchert A; Mox B; Jordaens L; Lamaison D; Gill J; Kaplan A; Merkely B;
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):646-52. PubMed ID: 15175058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is inappropriate therapy a resolved issue with current implantable cardioverter defibrillators?
    Brugada J
    Am J Cardiol; 1999 Mar; 83(5B):40D-44D. PubMed ID: 10089838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of outpatients experiencing implantable cardioverter defibrillator shocks associated with minimal symptoms.
    Hamer ME; Clair WK; Wilkinson WE; Greenfield RA; Pritchett EL; Page RL
    Pacing Clin Electrophysiol; 1994 May; 17(5 Pt 1):938-43. PubMed ID: 7517528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Inadequate therapeutic effects of implantable cardioverter/defibrillators: etiology, therapy and prevention].
    Mattke S; Dorwarth U; Müller D; Hoffmann E; Markewitz A; Kaulbach H; Schmöckel M; Steinbeck G
    Z Kardiol; 1994 May; 83(5):359-65. PubMed ID: 8053245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.